title: Drusen proteome analysis: an approach to the etiology of age-related macular degeneration.
abstract: Drusen are extracellular deposits that accumulate below the retinal pigment epithelium on Bruch's membrane and are risk factors for developing age-related macular degeneration (AMD). The progression of AMD might be slowed or halted if the formation of drusen could be modulated. To work toward a molecular understanding of drusen formation, we have developed a method for isolating microgram quantities of drusen and Bruch's membrane for proteome analysis. Liquid chromatography tandem MS analyses of drusen preparations from 18 normal donors and five AMD donors identified 129 proteins. Immunocytochemical studies have thus far localized approximately 16% of these proteins in drusen. Tissue metalloproteinase inhibitor 3, clusterin, vitronectin, and serum albumin were the most common proteins observed in normal donor drusen whereas crystallin was detected more frequently in AMD donor drusen. Up to 65% of the proteins identified were found in drusen from both AMD and normal donors. However, oxidative protein modifications were also observed, including apparent crosslinked species of tissue metalloproteinase inhibitor 3 and vitronectin, and carboxyethyl pyrrole protein adducts. Carboxyethyl pyrrole adducts are uniquely generated from the oxidation of docosahexaenoate-containing lipids. By Western analysis they were found to be more abundant in AMD than in normal Bruch's membrane and were found associated with drusen proteins. Carboxymethyl lysine, another oxidative modification, was also detected in drusen. These data strongly support the hypothesis that oxidative injury contributes to the pathogenesis of AMD and suggest that oxidative protein modifications may have a critical role in drusen formation.
authors.affiliation: Cole Eye Institute and Lerner Research Institute, Cleveland Clinic Foundation, and Department of Chemistry, Case Western Reserve University, OH 44195, USA. crabbj@ccf.org
authors.forename: John W
authors.initials: JW
authors.lastname: Crabb
authors.forename: Masaru
authors.initials: M
authors.lastname: Miyagi
authors.forename: Xiaorong
authors.initials: X
authors.lastname: Gu
authors.forename: Karen
authors.initials: K
authors.lastname: Shadrach
authors.forename: Karen A
authors.initials: KA
authors.lastname: West
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Sakaguchi
authors.forename: Motohiro
authors.initials: M
authors.lastname: Kamei
authors.forename: Azeem
authors.initials: A
authors.lastname: Hasan
authors.forename: Lin
authors.initials: L
authors.lastname: Yan
authors.forename: Mary E
authors.initials: ME
authors.lastname: Rayborn
authors.forename: Robert G
authors.initials: RG
authors.lastname: Salomon
authors.forename: Joe G
authors.initials: JG
authors.lastname: Hollyfield
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology*; D002829:Choroid / Q000473:pathology; D004798:Enzymes / Q000235:genetics; D005123:Eye / Q000473:pathology*; D005136:Eye Proteins / Q000235:genetics*; D006801:Humans; D008268:Macular Degeneration / Q000473:pathology*; D008875:Middle Aged; D015594:Optic Disk Drusen / Q000473:pathology*; D040901:Proteomics; D012016:Reference Values; D012160:Retina / Q000473:pathology
chemical_list: D004798:Enzymes; D005136:Eye Proteins